Iovance Biotherapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 808 | 0.0% | 295,997 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 545 | 0.0% | 250,939 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 315 | 0.0% | 183,116 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 677 | 0.0% | 203,241 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,504 | 0.0% | 203,241 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,779 | 0.0% | 189,467 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,565 | 0.0% | 195,180 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 2,912 | 0.0% | 196,461 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,922 | 0.0% | 236,358 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,125 | 0.0% | 247,331 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,658 | 0.0% | 235,573 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 978 | 0.0% | 160,054 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,042 | 0.0% | 163,007 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,542 | 0.0% | 160,973 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,821 | 0.0% | 164,937 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 2,858 | 0.0% | 171,647 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 3,565 | 0.0% | 186,741 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 5,597 | 0.0% | 226,963 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 6,475 | 0.0% | 248,831 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 7,824 | 0.0% | 247,116 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 11,514 | 0.0% | 248,146 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 8,000 | 0.0% | 243,022 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 6,392 | 0.0% | 232,871 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 5,331 | 0.0% | 178,078 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 4,954 | 0.0% | 178,961 | 12/31/2019 |